From: Discontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice
Baseline HBV DNA
Antiviral prophylaxis
HBV reactivation
HBV hepatitis
Yes*
Discontinuation
No
Undetectable (n = 20)
4 (20%)
12 (60%)
8 (40%)
2 (10%)
Detectable (n = 16)
7 (44%)
3 (19%)
6 (37%)
5 (31%)
4 (25%)